J.E. Sussman et al. / Journal of Organometallic Chemistry 694 (2009) 3506–3510
3507
mer (2a) 1H NMR (CDCl3): d, 7.33–7.56 (m, C6H5, 10H); 3.55 and
2.55 (m, –CH2–, 8H); 1.32 (m, –CH3, 30H). 13C{1H} NMR (CDCl3):
d, 133.1, 131.5, 130.8, 128.8 (m, C6H5, 12C); 92.2 (s, Cp*, 10C);
19.3 (m, –CH2–, 4C); 8.67 (s, –CH3, 10C). 31P{1H} NMR (CDCl3): d,
ꢀ19.6 (s, 2P). trans-isomer (2b) 31P{1H} NMR (CDCl3): d, ꢀ15.3 (s,
2P).
a
b
P
P
Ph
Ph
Ph
P
P
Ph
2.2.3. Synthesis of [Cp*Rh(Cl)(dpdpc)][PF6] (3)
A mixture of [Cp*RhCl2]2 (0.151 g, 0.25 mmol) and dpdpc
(0.322 g, 1.18 mmol) in 50 mL of degassed ethanol was refluxed
under N2 for 3 h after which the solution had turned bright red/or-
ange. Solvent was removed via vacuum and 8.5 mL of degassed
ethanol followed by a solution of ammonium hexafluorophosphate
(170 mg in 8.5 mL water) was added. A red precipitate formed, was
filtered and dried under vacuum leaving 48 mg (28% yield). Anal.
Calc. for C26H33ClF6P3Rh: C, 45.20; H, 4.81. Found: C, 45.28; H,
4.93%. 1H NMR (CDCl3): d, 7.75–7.58 (C6H5, m, 10H); 2.96, 2.58
and 2.32 (CH2, m, 8H); 1.44 (Cp*–CH3, s, 15H). 13C{1H} NMR
(CDCl3): d, 133.2, 131.3, 129.8, and 124.2 (m, C6H5, 6C); 103.2 (m,
Cp*, 5C); 25.2 and 21.3 (m, –CH2–, 4C); 9.01 (s, –CH3, 5C). 31P{1H}
cis-isomer
trans-isomer
Fig. 1. Structure of the (a) cis-dpdpc and (b) trans-dpdpc ligand.
and the
g
5-pentamethylcyclopentadienide (Cp*) ligand. The data
reported herein indicate the Rh(III) monomeric cationic complex
of dpdpc is formed through a bridged dimeric intermediate. X-
ray crystal structures of the dimeric [Cp*Rh(Cl)2]2(l-dpdpc) and
monomeric [Cp*Rh(Cl)(dpdpc)][PF6] will be reported.
1
NMR (CDCl3): d, 67.0 (d, JRh–P = 125.7 Hz, 2P); ꢀ143.7 (sept., PF6,
2. Experimental
1JP–F = 715.3 Hz, 1P).
2.1. General remarks
2.3. Single crystal X-ray structure analyses
Standard procedures for the manipulation of air-sensitive
materials were employed. Unless stated otherwise, all manipula-
tions were carried out at ambient temperature under an atmo-
sphere of dry argon or nitrogen gas using standard Schlenk,
syringe and high-vacuum line techniques. All solvents were dried
and distilled prior to use. The ruthenium, [Cp*RhCl2]2, and iridium,
[Cp*IrCl2]2, starting compounds (Sigma–Aldrich) were purchased
and used as received. Elemental analyses of the complexes were
performed by Huffman Laboratories in Goldon, CO USA. The
NMR spectra were recorded on a JEOL ESX-400 MHz instrument
and referenced using external standards. Infrared spectra were
recorded on a Thermo Nicolet Avatar 360 FT-IR spectrophotome-
ter. The dpdpc ligand was made according to literature procedure
[9].
X-ray quality crystals of the complexes 1b and 3 were grown by
slow evaporation of THF from a solution of the compounds. X-ray
intensity data were collected on a standard SMART 1K CCD diffrac-
tometer using graphite-monochromated Mo
Ka radiation,
k = 0.71073 Å. Absorption and other corrections were applied using
SADABS [16]. In all cases the space group was determined by obser-
vation of systematic absences and intensity statistics. Structures
were solved by direct methods using SHELXTL and refined by
full-matrix least squares on F2 [17]. Crystallographic details are
summarized in Table 1.
Table 1
Crystallographic and structure refinement parameters for 1 and 3.
2.2. Preparation of complexes 1–3
[Cp*Rh(Cl)2]2
(dpdpc) (1)
[Cp*Rh(Cl)(dpdpc)]
[PF6] (3)
2.2.1. Synthesis of [Cp*Rh(Cl)2]2(l-dpdpc) (1)
Chemical formula
Formula weight
Crystal system
Space Group
Crystal color and shape
Crystal size (mm3)
a (Å)
C18H24Cl2PRh
445.15
Triclinic
C30H41ClF6OP3Rh
762.90
Monoclinic
P2(1)
A mixture of [Cp*RhCl2]2 (0.151 g, 0.25 mmol) and dpdpc ligand
(0.068 g, 0.25 mmol) in 25 mL of degassed ethanol was refluxed
under N2 for 2 h, after which an orange precipitate formed. The
dark orange solid was filtered and dried under vacuum, leaving
100 mg (45% yield). Anal. Calc. for C36H48Cl4P2Rh2: C, 48.56; H,
5.43. Found: C, 48.20; H, 5.68%. cis-Isomer (1a) 1H NMR (CDCl3):
d, 7.67–7.29 (m, C6H5, 10H); 3.69 and 2.37 (m, –CH2–, 8H); 1.38
(m, –CH3, 30H). 13C{1H} NMR (CDCl3): d, 132.7, 131.1, 130.4 and
128.5 (m, C6H5, 12C); 98.6 (m, Cp*, 5C); 19.3 (m, CH2, 4C); 9.01
ꢀ
P1
Orange hexagonal plate Orange rod
0.20 ꢁ 0.12 ꢁ 0.05
8.7058(6)
13.6352(10)
16.4117(12)
71.103(4)
86.161(4)
85.464(4)
1835.6(2)
4
0.60 ꢁ 0.08 ꢁ 0.07
10.2073(5)
8.5765(5)
18.8761(10)
90
b (Å)
c (Å)
a
(°)
b (°)
99.420(3)
90
1630.19(15)
2
1.554
0.811
c
(°)
V (Å3)
(s, –CH3, 10C). 31P{1H} NMR (CDCl3): d, 14.1 (d, JRh–P = 138.7 Hz,
1
2P). trans-isomer (1b) 31P{1H} NMR (CDCl3): d, 18.0 (d, JRh–P
=
1
Z
Dcalc (Mg/m3)
1.611
1.303
138.7 Hz, 2P).
l
(mmꢀ1
)
Scan range (°)
Reflections collected
Independent reflections
Rint
1.58 < h < 33.35
67 364
14 122
2.02 < h < 33.36
20 635
11 031
2.2.2. Synthesis of [Cp*Ir(Cl)2]2(
A solution of dpdpc (0.038 g, 0.125 mmol) in 3.75 mL CH2Cl2
was added dropwise to solution of [Cp*IrCl2]2 (0.100 g,
0.125 mmol) in 3.15 mL CH2Cl2 that was cooled to 0 °C. The mix-
ture was then stirred overnight. The next morning the volume
was reduced by half, approximately 3 mL of ethanol was added,
followed by removal of solvents until an orange precipitate formed.
The orange solid was filtered, washed with ethanol and dried with
ether giving 69 mg of product (52% yield). Anal. Calc. for
C36H48Cl4P2Rh: C, 40.45; H, 4.53. Found: C, 40.11; H, 4.55%. cis-Iso-
l-dpdpc) (2)
0.0408
0.0357
a
Final R indices [I > 2
r
(I)]a
R1 = 0.0315,
wR2 = 0.0789
R1 = 0.0446,
wR2 = 0.0885
0.824
R1 = 0.0396,
wR2 = 0.0892
R1 = 0.0497,
wR2 = 0.0943
0.965
R indices (all data)a
Goodness-of-fit (GOF) on F2
Maximum, minimum
D
q
1.209, ꢀ1.150
1.271, ꢀ0.641
(e Åꢀ3
)
h
i
1=2
P
P
P
P
2
2
a
R1
¼
jjFoj ꢀ jFcjj= jFoj. wR2
¼
wðjFoj ꢀ jFcjÞ = wðFoÞ
.